# REaCT Integrated Consent Model to Compare Two Standard of Care Regimens

> **NCT02173262** · PHASE4 · COMPLETED · sponsor: **Ottawa Hospital Research Institute** · enrollment: 142 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** G-CSF
- **DRUG:** Ciprofloxacin

## Key facts

- **NCT ID:** NCT02173262
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2017-09
- **Final completion:** 2017-09
- **Target enrollment:** 142 (ACTUAL)
- **Last updated:** 2017-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02173262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02173262, "REaCT Integrated Consent Model to Compare Two Standard of Care Regimens". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02173262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*